Learning from osteoporosis: TCF4 as a promising companion biomarker for breast cancer
Int J Rheum Dis
.
2023 Jul;26(7):1220-1221.
doi: 10.1111/1756-185X.14674.
Authors
Jui-Hu Hsiao
1
,
Yi-Yu Chou
2
,
Chia-Jung Li
3
4
,
Yen-Dun Tony Tzeng
5
6
Affiliations
1
Department of Surgery, Kaohsiung Municipal Minsheng Hospital, Kaohsiung, Taiwan.
2
Department of Nursing, Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan.
3
Department of Obstetrics and Gynaecology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
4
Institute of Biopharmaceutical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan.
5
Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
6
Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan.
PMID:
37394890
DOI:
10.1111/1756-185X.14674
No abstract available
Publication types
Editorial
Comment
MeSH terms
Biomarkers
Breast Neoplasms* / genetics
Female
Humans
Osteoporosis* / diagnostic imaging
Osteoporosis* / drug therapy
Transcription Factor 4
Substances
Biomarkers
TCF4 protein, human
Transcription Factor 4
Grants and funding
KAFGH-D-112037/Kaohsiung Armed Forces General Hospital
KMSH-11201/Kaohsiung Municipal Minsheng Hospital
KSVGH112-042/Kaohsiung Veterans General Hospital
Ministry of Science and Technology, Taiwan
MOST 111-2314-B-075B-017/Ministry of Science Technology